Revance Therapeutics, Inc. ( NASDAQ:RVNC – Get Free Report ) shares hit a new 52-week low on Thursday following insider selling activity. The stock traded as low as $16.38 and last traded at $16.47, with a volume of 60252 shares changing hands. The stock had previously closed at $16.91. Specifically, Director Carey Oconnor Kolaja sold 2,500 shares of the business's stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $28.24, for a total transaction of $70,600.

https://www.dailypolitical.com/2023/09/09/revance-therapeutics-nasdaqrvnc-reaches-new-1-year-low-after-insider-selling.html

#dailypolitical